Taysha Gene Therapies, Inc. - COM SHS (TSHA)

Q4 2021 13F Holders as of 12/31/2021

Type / Class
Equity / COM SHS
Number of holders
64
Total Shares
18.5M
Shares change
-1.08M
Total reported value, excl. options
$216M
Value change
-$15.4M
Put/Call ratio
0
Number of buys
43
Number of sells
-13
Price
$11.65
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.